CMG Pharmaceutical Co. Ltd (058820) — Capital Reinvestment Ratio
Latest as of December 2024:
109.44x
CMG Pharmaceutical Co. Ltd (058820) has a Capital Reinvestment Ratio of 109.44x as of December 2024, meaning it reinvests 109% of its operating cash flow (₩290.09 Million) in capital expenditures (₩31.75 Billion). See CMG Pharmaceutical Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
109.44x
Capex / Operating Cash Flow
Operating Cash Flow
₩290.09 Million
KRW
Capital Expenditures
₩31.75 Billion
KRW
Data as of
Dec 2024
Most recent filing
CMG Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks CMG Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for CMG Pharmaceutical Co. Ltd from 2014 to 2024. For live market cap and broader valuation context, see 058820 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 109.44x | ₩290.09 Million | ₩31.75 Billion | ▲ +2706.1% |
| 2023 | 3.90x | ₩3.91 Billion | ₩15.25 Billion | ▲ +86.8% |
| 2022 | 2.09x | ₩4.94 Billion | ₩10.31 Billion | ▲ +197.4% |
| 2021 | 0.70x | ₩5.63 Billion | ₩3.95 Billion | ▼ -78.6% |
| 2020 | 3.28x | ₩2.94 Billion | ₩9.65 Billion | ▲ +13.2% |
| 2019 | 2.90x | ₩2.82 Billion | ₩8.18 Billion | ▲ +0.9% |
| 2018 | 2.87x | ₩886.78 Million | ₩2.55 Billion | ▲ +635.3% |
| 2017 | 0.39x | ₩1.95 Billion | ₩760.59 Million | ▲ +12.8% |
| 2016 | 0.35x | ₩2.31 Billion | ₩799.00 Million | ▼ -77.0% |
| 2015 | 1.51x | ₩2.41 Billion | ₩3.64 Billion | ▼ -88.4% |
| 2014 | 13.00x | ₩724.89 Million | ₩9.42 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow